Methoxetamine: Difference between revisions
>Josikins No edit summary |
>Josikins No edit summary |
||
Line 23: | Line 23: | ||
This substance was originally developed as a research chemical through the use of intelligent drug design. | This substance was originally developed as a research chemical through the use of intelligent drug design. | ||
<ref>Interview with a ketamine chemist | http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php</ref>. It is a chemical derivative of [[Ketamine]] that also contains structural features of [[phencyclidine|phencyclidine (PCP)]] and [[3-MeO-PCP]]. | <ref>Interview with a ketamine chemist | http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php</ref>. It is a chemical derivative of [[Ketamine]] that also contains structural features of [[phencyclidine|phencyclidine (PCP)]] and [[3-MeO-PCP]]. | ||
<ref>MXE Binding profile | http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/methoxetamine2012?view=Binary</ref> | <ref>MXE Binding profile | http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/methoxetamine2012?view=Binary</ref> | ||
MXE has almost no history of human usage prior and was first identified by the European Monitoring Centre for Drugs and Drug Addiction, which monitors the Internet for new psychoactive substances within the European Union, in November 2010. By July 2011, they had identified 58 websites selling the compound, at a cost of 145–195 euros for 10 grams. | |||
<ref>Online sales of new psychoactive substances/‘legalhighs’ | http://www.emcdda.europa.eu/attachements.cfm/att_143801_EN_SnapshotSummary.pdf</ref> | <ref>Online sales of new psychoactive substances/‘legalhighs’ | http://www.emcdda.europa.eu/attachements.cfm/att_143801_EN_SnapshotSummary.pdf</ref> | ||